RAPT Therapeutics, Inc. (NASDAQ:RAPT – Get Free Report) has been assigned an average recommendation of “Hold” from the nine ratings firms that are currently covering the stock, MarketBeat reports. One ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results